Groundbreaking Medical Improvements in Umbilical Cord Stem Cell Research
Physicians at the recent American Academy of Anti-Aging Medicine 26th Annual World Congress give a thumbs up to groundbreaking medicine
Medicine (A4M) and Metabolic Medical Institute (MMI)'s 26 th annual World Congress give a thumbs up to groundbreaking medical improvements by Liveyon — a regenerative medicine company leading the industry in umbilical cord stem cell research and clinical trials.
Having his own balding hair grow back and his wife's knee pain relieved is proof enough of the validity of umbilical stem cell medicine for Dr. Michael Valpiani, a medical doctor in Las Vegas and northern Arizona specializing in pain management. He's also a board certified anesthesiologist.
Valpiani, 67, said he treated his wife, Vivian, 58, with one umbilical cord stem cell
injection one year ago and she's been joint pain-free ever since. The bald spot he
previously had also re-grew hair with one treatment of a product he acquired through Liveyon, a regenerative medicine company leading the industry in stem cell research.
"I had tried other treatments with my hair, and with my wife there were other options to treat the pain, but I didn't want to do steroid injections into the joints," he said. "We elected to try and heal rather than treat the symptoms."
Valpiani said he's had a good success rate with Liveyon products in the one-year he's been using them on patients. "Nothing is ever 100 percent, but … all my family members and associates I have treated are satisfied with their results. I am very satisfied with the results I am achieving with Liveyon's products," he said.
One reason Valpiani said he's enthused about Liveyon products and excited to spread the word is because Liveyon uses umbilical cord stem cells — not the more controversial embryonic stem cells.
"Cellular therapy has been around for 30 years, for use with cancers and blood diseases, but we're not talking about the embryonic stem cells that have moral and ethical issues and risks involved. Liveyon has made a product that uses umbilical cord stem cells, this is what I'm excited about," he said.
"Liveyon supplies the educational support needed to train providers to use their products correctly. This is important to advance the proper use of cellular therapy," he added.
For many observers, medical breakthroughs in stem cell research and patients healed through clinical trials is thought to be either a rash of miracles or falsely reported outcomes.
The truth is somewhere in the middle, according to Dr. Ernesto Gutierrez, a medical doctor and faculty member with Universidad Anáhuac México, also known as Anáhuac University in Mexico City, where Gutierrez was a 2006 graduate.
Stem cell medicine "obviously isn't for everyone, but it's exciting what it can do. We're opening the doors of regenerative medicine and training doctors so they get the education and scientific knowledge they need," Gutierrez said, of his work with Liveyon, where he has served as chief operating officer since July. Gutierrez, 37, grew up in Mexico City, but currently lives in Brea, Calif., with his wife, Evelyn and the couple's 1-year-old son, Xavi.
After medical school, Gutierrez initially intended to be a pediatrician, but during his first few years in the field learned of regenerative medicine and became fascinated with the possibilities of stem cell usage. Prior to signing on with Liveyon, he set up and ran for a decade a clinic in Cancun, where he was involved in treating patients with stem cells. "I bring 12 years of clinical experience to the table," he said.
Gutierrez said his goal at the conference was to educate other medical professionals about research and protocols that weren't available or discussed when many of the physicians at the conference graduated from medical school, five or more years ago.
"Everything we do wasn't around back then, we are growing and developing the field," he said. "We want to make sure (the doctors) are using the highest standards." The importance of educating doctors about umbilical stem cell medicine before the physicians treat their patients with this breakthrough medicine became increasingly evident to scientists at Liveyon this past year.
The new Pure Product line has "an extremely high viability," he said, adding that there was a lot of testing and research involved, under guidelines set forth by the FDA.
Liveyon is a FDA registered facility and undergoes routine monitoring and inspection. More than 7,000 physicians and medical professionals from around the globe attended the weekend American Academy of Anti-Aging Medicine (A4M) and Metabolic Medical Institute (MMI)'s 26 th annual World Congress at the Venetian/Palazzo Resort.
The Liveyon's booth and workshops were among the most popular at the event.
"The draft regulations are pretty gray, so we want to help the doctors navigate and market to their patients, so they set realistic expectations,"
Stephanie DeGraw, Power Media Entertainment